Skip to main content
Premium Trial:

Request an Annual Quote

Snubbed, Miraculins Withdraws Offer to Acquire IBEX

NEW YORK (GenomeWeb News) — Canadian biomarker company Miraculins has withdrawn its offer to acquire diagnostics developer IBEX technologies.
 
In mid-November Winnipeg-based Miraculins made an unsolicited offer to acquire IBEX through a stock deal that would exchange one common Miraculins share for five shares in IBEX.
 
At the time, Montreal-based IBEX said the offer appeared to undervalue its worth, saying it had three times the holdings of Miraculins, and that Miraculins’ shares had dropped more than 100 percent since the beginning of the year.  
 
Today, Miraculins President Jim Charlton said “we were disappointed with the response received from IBEX's Board of Directors and have made the decision not to proceed with formalization of the offer at this time.”
 
Beyond the scuttle over valuation, which would leave Miraculins shareholders with 77 percent of the company and IBEX owners holding 23 percent, IBEX also was concerned about how the two companies’ technologies would be developed together.
 
As IBEX CEO Paul Baer told GenomeWeb News at the time of the original offer, “I think [Miraculins has] … undervalued our company … and we don’t understand how they propose to develop our technology with the resources they have.”
 
Baer said then that IBEX’s board would look more closely at the offer, but he suggested that it looked like an unlikely merger. “If their value was good, if their technology was good, if they were a well-traded stock it might be different,” he said.
The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.